Clinical and laboratory study
Congenital nevomelanocytic nevi: Proportionate area expansion during infancy and early childhood,☆☆

https://doi.org/10.1016/S0190-9622(96)90834-8Get rights and content

Abstract

Background: The way in which congenital nevomelanocytic nevi (CNN) expand relative to anatomic region during growth is relevant to decisions about optimal timing for surgical excision and assessment for malignant change.

Objective: Our purpose was to determine how CNN area expands relative to anatomic region during infancy and early childhood.

Methods: Forty-one small CNN in as many subjects were studied from the newborn period. Relative area (CNN area/anatomic region area) was derived for each measure. Proportionate expansion (PE), defined as change in relative area per unit time as a proportion of initial relative area, was calculated. Relative to anatomic region, area expansion of CNN is greater when PE is greater than 0, less when PE is less than 0, and at least double when PE is +1.0 or greater.

Results: From the newborn period to last measure (2 to 71 months), PE ranged from −0.7 to +8.8 (median, +0.1). For 66% of CNN (27 of 41), PE was greater than 0. Nine of 39 CNN (15.4%) had PE values of +1.0 or greater during the first 6 months, compared with 1 of 26 cases (3.8%) for the interval beginning at or after 6 months.

Conclusion: Disproportionately rapid area expansion of CNN may occur during early infancy, related to transient benign neoplasia, delayed pigmentation, and/or error of the methods used in the analysis.

References (37)

  • RG Walton et al.

    Pigmented lesions in newborn infants

    Br J Dermatol

    (1976)
  • JG Alper et al.

    The incidence and significance of birthmarks in a cohort of 4641 newborns

    Pediatr Dermatol

    (1983)
  • D DuBois et al.

    A formula to estimate the approximate surface area if height and weight be known

    Arch Intern Med

    (1916)
  • EA Gehan et al.

    Estimation of human body surface area from height and weight

    Cancer Chemother Rep

    (1970)
  • E Boyd

    The growth of the surface area of the human body

    (1935)
  • CC Lund et al.

    The estimation of areas of burns

    Surg Gynecol Obstet

    (1944)
  • AR Rhodes

    Neoplasms: benign neoplasias, hyperplasias, and dysplasias of melanocytes

  • RJ Starrico et al.

    Quantitative and qualitative data on the pigment cells of adult human epidermis

    J Invest Dermatol

    (1957)
  • Cited by (59)

    • Pigmented Lesions in Children: Update on Clinical, Histopathologic and Ancillary Testing

      2022, Dermatologic Clinics
      Citation Excerpt :

      It is now questioned, however, whether an axial location for large and giant CMN simply represents the most common site of involvement without independently portending a poor prognosis.12 During early infancy, a CMN may grow rapidly.17 In childhood, it is expected that a CMN will grow proportionally as a child grows.

    • Congenital Melanocytic Nevi

      2019, Pathology of Melanocytic Tumors
    • Perioral Lesions and Dermatoses

      2014, Dental Clinics of North America
    • Congenital Melanocytic Nevi

      2010, Pediatric Clinics of North America
      Citation Excerpt :

      Smaller lesions are thought to have lower risk for transformation than larger congenital nevi62 relative to the “nevus burden.” The risk for small CMN is controversial and is thought to be between and 0% and 4.0%,9,14,63,64 and for those with large or giant CMN the risk estimates are between 4.5% and 10.0%.62,65–71 Earlier estimates that were higher (as high as 42%) are now thought to be flawed from methodology or lack of improved histology.

    • Lentigines, nevi, and melanomas

      2009, Weedon's Skin Pathology: Third Edition
    View all citing articles on Scopus

    Supported in part by the Department of Public Health, Commonwealth of Massachusetts, contract No. 4513-1010 (Dr. Rhodes); National Institutes of Health grant No. 5T32-AR07098-15, and the Marion Gardner Jackson Trust (Dr. Albert); and National Cancer Institute grant No. 49531; National Institute of Arthritis, Musculoskeletal and Skin Disease grant No. 43051; and Department of Veterans Affairs Medical Research Funds (Dr. Weinstock).

    ☆☆

    Presented in part to the Society for Investigative Dermatology, April 29, 1992.

    Dr. Albert is currently in the private practice of dermatology in Milford, Massachusetts.

    View full text